Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.36M 1.25M 1.17M 2.21M 148M 2.25M 15.03M 5.84M 72.94M 5.85M 5.72M 251M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.31M -26.01M -24.25M -45.99M -3.08B -46.69M -312M -121M -1.52B -122M -119M -5.22B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 93.7 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -92.59% | 1.56M | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | -0.45% | +2.66% | +71.04% | +96.64% | 24.57B | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.75% | +137.74% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.3M 1.2M 1.12M 2.12M 142M 2.15M 14.37M 5.59M 69.74M 5.59M 5.47M 240M | 785K 686K 631K 588K 1.11M 74.74M 1.13M 7.57M 2.94M 36.74M 2.95M 2.88M 127M |
| Net income | -44.17M -38.61M -35.49M -33.08M -62.74M -4.21B -63.69M -426M -166M -2.07B -166M -162M -7.12B | -39.48M -34.51M -31.72M -29.56M -56.07M -3.76B -56.92M -381M -148M -1.85B -148M -145M -6.37B |
| Net Debt | -63.64M -55.63M -51.13M -47.65M -90.39M -6.06B -91.76M -614M -239M -2.98B -239M -234M -10.26B | -33.94M -29.67M -27.26M -25.41M -48.2M -3.23B -48.93M -327M -127M -1.59B -127M -125M -5.47B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
